scispace - formally typeset
Open AccessJournal ArticleDOI

Prolymphocytic transformation of chronic lymphocytic leukemia.

Carl R. Kjeldsberg, +1 more
- 01 Dec 1981 - 
- Vol. 48, Iss: 11, pp 2447-2457
Reads0
Chats0
TLDR
Patients with B‐cell chronic lymphocytic leukemia whose disease became more aggressive over a variable period of time were associated with a change in cell morphology from small lymphocytes to an increasing number of large transformed lymphocytes in the blood, bone marrow, and lymph nodes.
Abstract
This report describes eight patients with B-cell chronic lymphocytic leukemia whose disease became more aggressive over a variable period of time. This clinical progression was associated with a change in cell morphology from small lymphocytes to an increasing number of large transformed lymphocytes in the blood, bone marrow, and lymph nodes. In the peripheral blood, the predominant large cell was a prolymphocyte. The small lymphocytes and the prolymphocytes had identical cell surface markers in each patient. However, the prolymphocytes had a greater density of surface immunoglobulin than did the same lymphocytes. No features were found that help predict in which patients CLL will convert to a more aggressive form. Once transformation has taken place, however, there appears to be a correlation between the number of prolymphocytes in the blood and patient survival. It is suggested that the entities of prolymphocytic transformation of CLL, prolymphocytic leukemia, and Richter's syndrome are less distinct than has been thought previously. These disorders probably represent several phases of transformation of the same cell type, and they may be examples of different stages in the natural history of CLL.

read more

Citations
More filters
Journal ArticleDOI

Chronic Lymphocytic Leukemia: New Insights into Biology and Therapy

TL;DR: Major advances in the biologic research of chronic lymphocytic leukemia have resulted in new understanding of this complex disease, and new therapies such as those with intravenous immunoglobulin and fludarabine may lead to improved outcome.
Journal ArticleDOI

The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group.

TL;DR: It is suggested that although PLL cannot be considered as the extreme end of a continuous spectrum from typical CLL, the spleen may be the source of PROL both in PLL and in CLL/PL.
Journal ArticleDOI

The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. II. Patterns of evolution of 'prolymphocytoid' transformation.

TL;DR: The degree of concordance in the assessment of cell size between morphology and volume measurements was high in CLL, whereas in C LL/PL and PLL morphology underestimated the cell.
Journal ArticleDOI

Chronic Lymphocytic Leukemia: Recent Advances in Biology and Treatment

TL;DR: Alkylating agents, radiation therapy, and corticosteroids are commonly used to treat patients with chronic lymphocytic leukemia, and recently, biological response modifiers such as monoclonal antibodies and interferon have been studied.
Journal ArticleDOI

The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. IV. Analysis of survival and prognostic features.

TL;DR: In this paper, the prognostic value of biological, clinical and laboratory features was analysed in a series of 265 patients with chronic lymphocytic leukaemia (CLL) and prolymphocyte-cytokine-leukemia (PLL) in order to identify the cases of CLL/PL that behave as PLL, and as such may benefit from different treatment.
References
More filters
Journal ArticleDOI

Clinical staging of chronic lymphocytic leukemia.

TL;DR: The proposed staging system was an equally accurate indicator for survival when applied to two other previously published studies of large series of patients and sex and age were shown to be poor predictors of survival after adjustment for stage.
Journal ArticleDOI

Histochemical methods for acid phosphatase using hexazonium pararosanilin as coupler

TL;DR: ‘[he use of freslsbv diazotizecl pararosanilin w-itim a-msaphthyb pisosphate its a sinmultaneous coupling azo dye method for acid phosphatase resulted in significant improveumment because of the nmaumy desirable characteristics of the final azo dyed (1, 2).
Journal Article

Immunoperoxidase techniques: practical and theoretical aspects.

TL;DR: The relative merits of the various immunoperoxidase procedures are examined, and theoretical and practical aspects governing the application of these methods are discussed in detail.
Related Papers (5)